Should I Buy AQB? AQB 2026 Analysis

Should You Buy AquaBounty Technologies Inc (AQB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

0.960

1 Day change

-1.64%

52 Week Range

2.950

Analysis Updated At

2026/01/28

Not a good buy right now for a beginner long-term investor with $50k–$100k. AQB is a highly speculative micro-cap with effectively no revenue in the latest reported quarter and worsening losses YoY, while technicals show no strong uptrend and Intellectia signals show no buy setup. Given your impatience for optimal entries, this does not offer a clear, high-conviction long-term entry today.

Technical Analysis

Pre-market price is ~1.01, trading below the pivot (1.055) and closer to support (S1 0.952) than resistance (R1 1.158), which suggests the stock is not currently in a strong bullish posture. - Momentum: MACD histogram is positive (0.0118) but positively contracting, implying bullish momentum exists but is fading. - RSI(6): 52.4 (neutral), showing no overbought/oversold edge. - Moving averages: converging, which typically signals consolidation/indecision rather than a trend. - Near-term pattern stats: modest chance of a small next-day move, but the next-month projection is negative (-6.87%), which is unfavorable for a long-term entry right now. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Positive Catalysts

- Technical positioning near S1 (0.952) could allow for a short-term bounce if buyers defend support.
- MACD remains above zero, indicating residual positive momentum despite weakening.

Neutral/Negative Catalysts

- No recent news in the past week; no positive event-driven catalyst is visible.
- Hedge fund and insider activity trends are neutral (no accumulation signal).
- No Intellectia buy signals (AI Stock Picker / SwingMax) to support an aggressive entry.
- Pattern-based outlook shows negative bias over the next month (-6.87%).
- No recent congress trading data available (no supportive “influential buyer” signal).

Financial Performance

Latest quarter: 2025/Q3. Revenue was 0 (no YoY growth), while Net Income declined to -1,380,773 (down 59.44% YoY) and EPS fell to -0.36 (down 59.09% YoY). This indicates ongoing losses with no demonstrated revenue base in the quarter—an unfavorable setup for a beginner long-term allocation.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so a clear Wall Street consensus/trend cannot be confirmed from this dataset. With available information dominated by weak fundamentals (no revenue, larger losses) and no strong technical or proprietary buy signals, the pro view would likely hinge on speculative future execution, while the con view is near-term financial weakness and lack of traction.

Analyst Rating

Wall Street analysts forecast AQB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AQB is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold